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ABSTRACT (275 words max)  
The extent to which vitamin E (alpha-tocopherol) intake early in childhood is associated 
with alanine aminotransferase (ALT) level later in childhood is unknown. The objective 
of this research is to test the hypothesis that higher alpha-tocopherol intake during early 
childhood is associated with lower odds of elevated ALT levels during mid-childhood, 
and to examine how body mass index (BMI) influences these relationships. We studied 
528 children in Project Viva. Mothers reported child dietary intake at early childhood 
visits (median 3.1 years) using a validated food frequency questionnaire. At mid-
childhood (median 7.6 years), we collected child blood and anthropometric data. The 
main outcome was elevated sex-specific mid-childhood ALT level (≥ 22.1 units/liter for 
females and ≥ 25.8 units/liter for males). In multivariable logistic regression models, we 
assessed the association of energy-adjusted alpha-tocopherol intake with ALT levels, 
adjusting for child age, sex, race/ethnicity, diet, and age-adjusted, sex-specific BMIz at 
mid-childhood. Among children in this study, 48% were female, 63% were non-Hispanic 
white, 19% were non-Hispanic black, and 4% Hispanic/Latino. Mean alpha-tocopherol 
intake was 3.7±1.0 mg/day (range 1.4-9.2) at early childhood.  At mid-childhood, mean 
BMIz was 0.41±1.0 units and 22% had an elevated ALT level. In multivariable-adjusted 
logistic regression models, children with higher early childhood vitamin E intake had 
lower odds of elevated mid-childhood ALT [adjusted odds ratio (AOR) 0.62 (95% CI: 
0.39-0.99)] for quartiles 2-4 compared with the lowest quartile of intake. Findings 
persisted after accounting for early childhood diet [0.62 (0.36, 1.08)] and were 
strengthened after additionally accounting for mid-childhood BMIz [0.56 (0.32, 0.99)]. 
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Conclusion:  In this cohort, higher early childhood intake of alpha-tocopherol was 
associated with lower odds of elevated mid-childhood ALT level.
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Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in 
children, and the prevalence of pediatric NAFLD has increased rapidly over the past two 
decades.(1, 2) The term NAFLD encompasses a variety of disease phenotypes including simple 
steatosis, steatohepatitis, and fibrosis; the hallmark of each is hepatic steatosis (fat infiltration of 
liver cells) without alternative causes.(3) An estimated 40% of children with overweight (sex-
specific body mass index [BMI] ≥ 85
th
 and <95
th
 percentile for age) and obesity (BMI ≥ 95
th
 
percentile), and around one in ten children age 2-19 years of all weight categories, have 
NAFLD.(2, 4, 5) In cross-sectional pediatric studies, older age, race/ethnicity, and male sex are 
risk factors.(4, 6-8) Long-term complications may include cirrhosis and hepatocellular 
carcinoma, and NAFLD has emerged as the most rapidly growing cause of hepatocellular 
carcinoma requiring liver transplant among adults in the United States.(9)  
 
Expert committees have recommend use of serum alanine aminotransferase (ALT) levels to 
screen for NAFLD among at-risk children.(10, 11) In adults of all BMI categories, continuous 
increases in serum ALT levels are associated with hepatocellular carcinoma risk, type 2 diabetes 
risk, and mortality.(12) Among children ages 12-19 years, thresholds for serum ALT >25.8 
units/liter for males and >22.1 for females show 80-92% sensitivity and 79-85% specificity to 
detect pediatric NAFLD, and have been used in epidemiologic studies to estimate prevalence of 
NAFLD.(2, 13) Given the high proportion of adolescents with elevated plasma ALT levels,(2) 
early and mid-childhood could be key windows of opportunity to prevent rising ALT levels. 
Moreover, identifying protective factors against elevated ALT levels could inform future 
interventions to prevent pediatric NAFLD. Yet, little information exists on etiologies of elevated 
ALT levels during childhood. 
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Vitamin E is a prime candidate for protection against development of NAFLD because its anti-
oxidant properties may combat lipotoxic effects of free fatty acids and metabolites, which play a 
role in hepatocellular damage. Among children and adolescents with biopsy-proven 
steatohepatitis, higher intake of the alpha-tocopherol isoform of vitamin E had a cross-sectional 
correlation with lower degree of steatosis and alpha-tocopherol supplementation improved 
histologic outcomes in a randomized-controlled trial.(2, 14) Identifying the prospective 
association of alpha-tocopherol intake during early childhood with later ALT levels could inform 
future efforts to prevent liver damage in children. 
 
The overall goal of this research was to prospectively examine the relationship of alpha-
tocopherol intake during early childhood with subsequent ALT levels, and to ascertain the extent 
to which mid-childhood adiposity mediates this relationship. We hypothesized that higher intake 
of alpha-tocopherol during early childhood would be associated with lower odds of elevated 
ALT levels later in childhood, and that this relationship would operate independent of child age- 
and sex-specific BMI (BMI z-score). 
 
METHODS 
Study Design and Participants 
We studied children in Project Viva, an ongoing prospective pre-birth cohort study. Pregnant 
women were recruited from Atrius Harvard Vanguard Medical Associates, a multi-specialty 
group practice in eastern Massachusetts. Study recruitment and retention details are described 
elsewhere.(15) Mothers gave written informed consent at enrollment in pregnancy and at in-
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person visits in early (median age 3.1 years) and mid-childhood (median child age 7.6 years), 
and children gave verbal assent at mid-childhood. The institutional review board of Harvard 
Pilgrim Health Care approved all study protocols. 
 
Of the 2128 live singleton births in the cohort, 1708 remained enrolled and thus were eligible for 
a mid-childhood study visit and 1116 attended an in-person visit between age 6 and 10 years. Of 
those, 635 had blood available for ALT analysis; 534 of those had information on early 
childhood dietary intake; and 528 had information on BMI z-score at mid-childhood and form 
the study population for this analysis. Characteristics of the study sample of 528 were similar to 
the 588 who attended a mid-childhood visit but did not have blood available for ALT analysis in 
terms of maternal age and pre-pregnancy BMI; child sex; and BMI z-score at mid-childhood 
(data not shown). However, compared to children with mid-childhood visits not included in this 
analysis, children in our study sample had slightly lower mean age at early (38.3 ± 2.7 versus 
39.1 ± 4.9 months) and mid-childhood (94.2 ± 8.9 versus 97.7 ± 11.5 months) visits.  
 
Measurements 
Main Exposure: Early childhood alpha-tocopherol intake. Vitamin E intake measured as alpha-
tocopherol during early childhood was the main exposure. At early childhood visits, parents 
reported children’s dietary intake by completing a semi-quantitative food frequency 
questionnaire that was validated for use in pre-school aged children, including for measurement 
of alpha-tocopherol intake.(16) Questions assessed usual frequency of intake of specific food and 
drink. We calculated nutrient intakes using the Harvard nutrient composition database, which is 
based primarily on U.S. Department of Agriculture information, and it is continually 
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supplemented by other published sources.(17-19) We estimated energy-adjusted total daily 
alpha-tocopherol intake from foods using the nutrient residual method. We categorized alpha-
tocopherol intake during early childhood into quartiles based on the sample of children with 
available alpha-tocopherol intake information. We defined insufficient alpha-tocopherol intake 
based on age-specific recommended daily allowance (RDA) for alpha-tocopherol.(20) The 
current RDA for natural alpha-tocopherol is 6 mg for children age 1-3 years, and 7 mg for 
children age 4-8 years. However, because self-reported insufficient alpha-tocopherol intake has 
high prevalence nationally,(20) we additionally defined low alpha-tocopherol intake as the 
lowest quartile (< 2.98 mg/day).  
 
Main Outcome: Mid-childhood ALT level. We collected blood samples from children at the mid-
childhood visit. Samples were processed within 24 hours and frozen at -80° C until the time of 
analysis. We measured concentration of ALT by enzymatic assay on the Roche P Modular 
system using Roche reagents (Roche Diagnostics, Indianapolis, IN). This assay is approved by 
the Food and Drug Administration for clinical use and standardized across centers. The lowest 
detection limit of this assay is 4 U/L and the day-to-day imprecision values at concentrations of 
42, 55 and 130 U/L are 4.4, 3.7 and 3.3%, respectively. We classified elevated ALT levels as ≥ 
25.8 units/liter for males and ≥ 22.1 for females.(2, 13) 
 
Covariates. At recruitment during pregnancy, we collected information including maternal age, 
education, parity and pre-pregnancy weight and height; and paternal weight and height. Child 
sex was documented at delivery. At early childhood, we collected information about marital 
status; household income; and child race/ethnicity. We also collected data on diet and physical 
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activity factors at early childhood that could act as confounders of the relationship between 
alpha-tocopherol intake and ALT level. As described above for alpha-tocopherol intake, mothers 
provided information on child diet using a semi-quantitative validated food frequency 
questionnaire. Based on existing literature on dietary factors that could be related to NAFLD in 
children,(21, 22) we estimated daily intakes of fruit and vegetable; sugar-sweetened beverages; 
total energy intake in calories; and energy-adjusted total fat, carbohydrates, protein, saturated fat, 
polyunsaturated fat, fructose, vitamin D, and vitamin C intake using the nutrient residual 
method.(16) Mothers reported child moderate-to-vigorous daily physical activity at early 
childhood.(23) 
 
Potential intermediates. We examined mid-childhood BMI z-score as a potential intermediate of 
the relationship between  alpha-tocopherol intake. We measured height and weight of children 
using a calibrated stadiometer (Shorr Productions, Olney, MD) and scale (Seca model 881, Seca 
corporation, Hanover, MD). We calculated age- and sex-specific BMI z-scores using CDC 2000 
growth reference data.(24) Research assistants followed standardized techniques for 
measurements and participated in in-service training to ensure measurement validity (IJ Shorr, 
Shorr Productions, Olney, MD).(25) Inter- and intra-rater measurement errors were within 
published reference ranges for all measurements.(26)  
 
Statistical Analysis  
We first examined the bivariate relationships of alpha-tocopherol intake with other covariates 
and the main outcome. We used logistic regression models to assess the effect of low alpha-
tocopherol intake at early childhood with high ALT level at mid-childhood. We also examined 
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the relationship between each quartile of alpha-tocopherol intake and ALT outcomes. In 
multivariable models, we included only those covariates that were of a priori interest based on 
prior literature. The covariate-adjusted model included child age, sex, and race/ethnicity. In 
subsequent models, we additionally adjusted for individual dietary factors that had a statistically-
significant correlation (p-value > 0.01) with vitamin E intake at early childhood and could 
therefore act as confounders of the association between alpha-tocopherol and ALT level. The 
diet-adjusted model included fruit, vegetable, energy-adjusted saturated fat, energy-adjusted 
polyunsaturated fat, fructose, vitamin D, and vitamin C intake at early childhood.  To account for 
the potential intermediate of BMI z-score at mid-childhood, we additionally adjusted the 
covariate-adjusted and the diet-adjusted models for  mid-childhood BMI z-score. 
 
Because ALT levels differ between males and females, we also investigated whether child sex 
modified the effect estimate of early childhood alpha-tocopherol intake and mid-childhood 
elevated ALT level. We conducted all of the analyses using SAS version 9.4 (SAS Institute, Inc., 
Cary, North Carolina). 
 
RESULTS 
Table 1 shows family and child characteristics of the 528 children included in our analyses. 48% 
were female, 63% were non-Hispanic white, 19% were non-Hispanic black, 4% Hispanic/Latino, 
and 2% were Asian. At early childhood, fruit and vegetable intake; and energy-adjusted saturated 
fat, polyunsaturated fat, fructose, vitamin D, and vitamin C intake were correlated with vitamin E 
intake (p-value < 0.001). Sugar-sweetened beverage intake, calories, total fat, carbohydrate, and 
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protein intake were not correlated with alpha-tocopherol intake at early childhood. (Data not 
shown) 
 
Table 2 shows total energy and energy-adjusted alpha-tocopherol intake during early childhood 
by mid-childhood ALT category. At mid-childhood, 22% of children had elevated ALT levels. 
Children with high mid-childhood ALT levels had similar maternal-reported early childhood 
mean total energy intake as those with normal mid-childhood ALT levels.  
 
In Table 3, we present results from logistic regression models testing our first hypothesis of the 
effects of early childhood alpha-tocopherol intake on mid-childhood ALT levels. In unadjusted 
models, compared to children with the lowest quartile of alpha-tocopherol intake, those with 
higher alpha-tocopherol intake (quartiles 2-4) had lower odds of elevated ALT level [odds ratio 
(OR) 0.65 (95% CI: 0.41, 1.02)]. After adjusting for a priori confounders, these findings 
persisted [OR 0.62 (0.39, 0.99)]. In models examining quartiles of alpha-tocopherol intake, 
children in the 3
rd
 quartile of alpha-tocopherol intake had lower odds of elevated ALT at mid-
childhood compared to those with the lowest quartile of intake in unadjusted [OR 0.48 (0.27, 
0.88)] and child-adjusted models [OR 0.43 (0.23,0.80)]. We also found lower odds of ALT 
elevation among children in the 2
nd
 and 4
th
 quartiles of alpha-tocopherol intake compared to 
those with the lowest quartile of intake, but confidence intervals were wide and included the null. 
We did not find any modification of the effect of alpha-tocopherol intake and ALT elevation by 
child sex (p-interaction > 0.1 for all models). 
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We then examined the extent to which dietary factors correlated with alpha-tocopherol intake at 
early childhood accounted for the relationship between alpha-tocopherol intake and ALT 
elevation. In models adjusted for child age, sex, race/ethnicity, and individual dietary factors, we 
found that adjusting for vegetable, polyunsaturated fat, or vitamin D intake slightly attenuated 
the relationship between alpha-tocopherol intake at early childhood and elevated ALT at mid-
childhood (Figure 1). After adjusting for fruit, saturated fat, fructose, or vitamin C intake, the 
association of higher alpha-tocopherol intake at early childhood with lower odds of elevated 
ALT at mid-childhood persisted. In the diet-adjusted model, children with higher vitamin E 
intake (quartiles 2-4) had similar odds of elevated ALT level as in the covariate-adjusted model, 
but confidence intervals widened and crossed the null. In models examining the association of 
each quartile of alpha-tocopherol intake with elevated ALT level, findings were similar to the 
covariate-adjusted model.  
 
We next investigated our hypothesis that the relationship between early childhood alpha-
tocopherol intake and elevated ALT level at mid-childhood would be independent of mid-
childhood adiposity. Mid-childhood BMI z-score was highest in the 2
nd
 and 3
rd
 quartiles of early 
childhood alpha-tocopherol intake (Table 1).  We did not find a correlation between early 
childhood alpha-tocopherol intake and mid-childhood BMI z-score (Spearman r = 0.06, p = 
0.15), but BMI z-score had a cross-sectional correlation with ALT at mid-childhood (Spearman r 
= 0.21, p <0.001). After adjusting our models of early childhood alpha-tocopherol intake and 
mid-childhood elevated ALT for mid-childhood BMI z-score, we found lower odds ratios with 
narrower confidence intervals for models comparing 2
nd
-4
th
 quartiles to the lowest quartile of 
intake [OR 0.55 (0.34, 0.89)]. In models comparing individual quartiles to the lowest quartile of 
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alpha-tocopherol intake, adjusting for BMI z-score resulted in strengthening of associations of 
alpha-tocopherol quartile with ALT elevation (e.g. among children in the 3
rd
 vs. 1
st
 quartile of 
intake [OR 0.37 (0.20, 0.69)]).  
 
In our final model adjusting for covariates, early childhood diet, and mid-childhood BMI z-score, 
findings persisted but confidence intervals widened in models comparing 2
nd
-4
th
 quartiles [OR 
0.56 (0.32, 0.99)] to the lowest quartile, as well as in models comparing individual quartiles to 
the lowest quartile of alpha-tocopherol intake.  
 
DISCUSSION  
In this prospective cohort study, children with higher alpha-tocopherol intake during early 
childhood had lower likelihood of elevated ALT levels at mid-childhood. Overall, the 
relationship between higher alpha-tocopherol intake and lower odds of elevated ALT persisted 
after accounting for demographic and dietary confounders. Accounting for mid-childhood BMI 
z-score strengthened the relationship between higher alpha-tocopherol intake at early childhood 
and lower odds of ALT elevation at mid-childhood. Taken together, these findings suggest that 
appropriate levels of alpha-tocopherol intake could promote liver health later in childhood, and 
that this relationship is not mediated by an effect of alpha-tocopherol intake on BMI. 
 
Our study is the first of which we are aware to demonstrate a link between early childhood 
dietary risk factors and later childhood liver health. We prospectively examined a modifiable risk 
factor for elevated plasma ALT levels during mid-childhood. Plasma or serum ALT levels are 
used to screen for pediatric NAFLD, a prevalent childhood obesity complication. Although little 
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information on the natural history of NAFLD in children exists, fibrosis/cirrhosis and end-stage 
liver disease can occur even in childhood. Thus, identifying alpha-tocopherol as an early 
childhood protective factor against later elevation of ALT levels suggests that future 
interventions to study approaches to prevent development and progression of pediatric NAFLD 
should take early childhood alpha-tocopherol consumption into account. National data shows 
that >90% of the US population under-consumes alpha-tocopherol, leading to the classification 
of vitamin E as a shortfall nutrient by the 2015 Dietary Guidelines Advisory Committee.(27) 
Given the high prevalence of both inadequate vitamin E consumption and NAFLD, our findings 
are relevant to the general US population. 
 
Lower alpha-tocopherol intake is a plausible risk factor for elevated ALT levels and NAFLD. 
Substantial evidence shows a link between intake of the fat-soluble antioxidant vitamin E and 
severity of NAFLD in children with biopsy-proven steatohepatitis. In a cross-sectional study of 
children with biopsy-proven steatohepatitis, intake of alpha-tocopherol was inversely related to 
steatosis grade.(21) In the multi-center, placebo-controlled Treatment of Nonalcoholic Fatty 
Liver Disease in Children (TONIC) trial, children with established NAFLD who received 
vitamin E as alpha-tocopherol 400 IU twice daily had improvement in histological outcomes 
after 96 weeks, but did not have a statistically significant improvement in ALT levels compared 
to the placebo group.(28) In the Pioglitazone vs. Vitamin E vs. Placebo in Non-alcoholic 
Steatohepatitis (PIVENS) randomized-controlled trial, vitamin E supplementation improved 
ALT levels among adults regardless of whether they lost, gained, or maintained stable 
weight.(29) Thus, our results extend the existing literature showing alpha-tocopherol treatment 
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effect in established NAFLD to suggest that alpha-tocopherol intake early in childhood could 
have a protective role against liver injury later in childhood. 
 
We hypothesized that the association between alpha-tocopherol intake and ALT would be 
independent of BMI z-score. In a recent adult clinical trial, presence of metabolic syndrome 
lowered the bioavailability of alpha-tocopherol after ingestion of doses compatible with the 
RDA, suggesting that higher oxidative stress and inflammation increases alpha-tocopherol 
requirements.(30) However, in our study, we found no relationship between early childhood 
alpha-tocopherol intake and mid-childhood BMI z-score. Children with overweight or obesity 
are more likely to have elevated ALT levels than children with a healthy weight, and we did find 
a relationship between mid-childhood BMI z-score and ALT level. Adjusting for mid-childhood 
BMI z-score resulted in further reduction of odds of ALT elevation among children with higher 
alpha-tocopherol intake, suggesting that the beneficial effects of early childhood alpha-
tocopherol intake were not mediated by mid-childhood BMI z-score. 
 
In the TONIC trial, children received 400 IU, or 180 milligrams, of alpha-tocopherol twice daily. 
Our study sample had early childhood alpha-tocopherol intake, measured as α-tocopherol, 
ranging from 1.4 – 9.2 milligrams, substantially below the supplemental amounts in the TONIC 
trial. Also, Vitamin E is present in foods that are more often consumed by those with healthful 
diets, such as wheat germ, almonds, spinach, and broccoli, as well as cooking oils,(27) and less 
often by young children. We included alpha-tocopherol intake from diet and supplements in our 
calculations, but cannot distinguish the contribution of various foods or supplements to alpha-
tocopherol intake.  
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Strengths of our study include the prospective nature of the design and its evaluation of a 
modifiable risk factor during a life course period that is important to prevention of pediatric 
NAFLD. However, we also note some limitations. Because this is a population-based cohort, we 
did not have liver imaging or liver tissue available for analysis, which limits our ability to 
determine grade and stage of liver disease. However, in clinical guidelines, ALT levels are the 
recommended test for NAFLD screening and substantial evidence shows that higher ALT levels 
are linked to morbidity and mortality, supporting the importance of ALT levels as a health 
outcome. Second, we estimated vitamin E intake based on parental report of child diet, which 
could be prone to over or underestimation. Finally, we had small sample sizes of Asian and 
Hispanic children. Because these racial/ethnic groups are more likely to have NAFLD compared 
to non-Hispanic white or black children,(2) our effect estimates may underestimate the 
association alpha-tocopherol intake with circulating ALT levels.   
 
In summary, we found that higher intake of the alpha-tocopherol isoform of vitamin E during 
early childhood was associated with lower odds of elevated ALT level during mid-childhood. 
Our findings suggest that modifiable risk factors, specifically intake of vitamin E, should be 
considered in future interventions to identify approaches to prevent pediatric NAFLD.  
Page 16 of 27
Hepatology
Hepatology
This article is protected by copyright. All rights reserved.
17 
 
 
REFERENCES 
1. Senechal M, Wicklow B, Wittmeier K, Hay J, MacIntosh AC, Eskicioglu P, Venugopal 
N, et al. Cardiorespiratory fitness and adiposity in metabolically healthy overweight and obese 
youth. Pediatrics 2013;132:e85-92. 
2. Welsh JA, Karpen S, Vos MB. Increasing prevalence of nonalcoholic fatty liver disease 
among United States adolescents, 1988-1994 to 2007-2010. J Pediatr 2013;162:496-500 e491. 
3. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, et al. 
The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the 
American Gastroenterological Association, American Association for the Study of Liver 
Diseases, and American College of Gastroenterology. Gastroenterology 2012;142:1592-1609. 
4. Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, Behling C. Prevalence of 
fatty liver in children and adolescents. Pediatrics 2006;118:1388-1393. 
5. Anderson EL, Howe LD, Jones HE, Higgins JP, Lawlor DA, Fraser A. The Prevalence of 
Non-Alcoholic Fatty Liver Disease in Children and Adolescents: A Systematic Review and 
Meta-Analysis. PLoS One 2015;10:e0140908. 
6. Ogden CL, Carroll MD, Lawman HG, Fryar CD, Kruszon-Moran D, Kit BK, Flegal KM. 
Trends in Obesity Prevalence Among Children and Adolescents in the United States, 1988-1994 
Through 2013-2014. Jama 2016;315:2292-2299. 
7. Santoro N, Kursawe R, D'Adamo E, Dykas DJ, Zhang CK, Bale AE, Cali AM, et al. A 
common variant in the patatin-like phospholipase 3 gene (PNPLA3) is associated with fatty liver 
disease in obese children and adolescents. Hepatology 2010;52:1281-1290. 
Page 17 of 27
Hepatology
Hepatology
This article is protected by copyright. All rights reserved.
18 
 
 
8. Goffredo M, Caprio S, Feldstein AE, D'Adamo E, Shaw MM, Pierpont B, Savoye M, et 
al. Role of TM6SF2 rs58542926 in the pathogenesis of nonalcoholic pediatric fatty liver disease: 
A multiethnic study. Hepatology 2016;63:117-125. 
9. Wong RJ, Cheung R, Ahmed A. Nonalcoholic steatohepatitis is the most rapidly growing 
indication for liver transplantation in patients with hepatocellular carcinoma in the U.S. 
Hepatology 2014;59:2188-2195. 
10. Barlow SE. Expert committee recommendations regarding the prevention, assessment, 
and treatment of child and adolescent overweight and obesity: summary report. Pediatrics 
2007;120 Suppl 4:S164-192. 
11. Vos MB, Abrams SH, Barlow SE, Caprio S, Daniels SR, Kohli R, Mouzaki M, et al. 
NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty 
Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) 
and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition 
(NASPGHAN). J Pediatr Gastroenterol Nutr 2017;64:319-334. 
12. Kim CH, Park JY, Lee KU, Kim JH, Kim HK. Association of serum gamma-
glutamyltransferase and alanine aminotransferase activities with risk of type 2 diabetes mellitus 
independent of fatty liver. Diabetes Metab Res Rev 2009;25:64-69. 
13. Schwimmer JB, Dunn W, Norman GJ, Pardee PE, Middleton MS, Kerkar N, Sirlin CB. 
SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of 
pediatric chronic liver disease. Gastroenterology 2010;138:1357-1364, 1364 e1351-1352. 
14. Lavine JE, Schwimmer JB, Van Natta ML, Molleston JP, Murray KF, Rosenthal P, 
Abrams SH, et al. Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver 
Page 18 of 27
Hepatology
Hepatology
This article is protected by copyright. All rights reserved.
19 
 
 
disease in children and adolescents: the TONIC randomized controlled trial. JAMA 
2011;305:1659-1668. 
15. Oken E, Baccarelli AA, Gold DR, Kleinman KP, Litonjua AA, De Meo D, Rich-Edwards 
JW, et al. Cohort profile: project viva. Int J Epidemiol 2015;44:37-48. 
16. Blum RE, Wei EK, Rockett HR, Langeliers JD, Leppert J, Gardner JD, Colditz GA. 
Validation of a food frequency questionnaire in Native American and Caucasian children 1 to 5 
years of age. Matern Child Health J 1999;3:167-172. 
17. Willett WC, Sampson L, Stampfer MJ, Rosner B, Bain C, Witschi J, Hennekens CH, et 
al. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J 
Epidemiol 1985;122:51-65. 
18. Oken E, Kleinman KP, Olsen SF, Rich-Edwards JW, Gillman MW. Associations of 
seafood and elongated n-3 fatty acid intake with fetal growth and length of gestation: results 
from a US pregnancy cohort. Am J Epidemiol 2004;160:774-783. 
19. Gillman MW, Rifas-Shiman SL, Kleinman KP, Rich-Edwards JW, Lipshultz SE. 
Maternal calcium intake and offspring blood pressure. Circulation 2004;110:1990-1995. 
20. Institute of Medicine (US) Panel on Dietary Antioxidants and Related Compounds. 
Dietary Reference Intakes: Vitamin C, Vitamin E, Selenium, and Carotenoids. 
https://www.ncbi.nlm.nih.gov/books/NBK225483/ doi: 10.17226/9810; 2000. 
21. Vos MB, Colvin R, Belt P, Molleston JP, Murray KF, Rosenthal P, Schwimmer JB, et al. 
Correlation of vitamin E, uric acid, and diet composition with histologic features of pediatric 
NAFLD. J Pediatr Gastroenterol Nutr 2012;54:90-96. 
Page 19 of 27
Hepatology
Hepatology
This article is protected by copyright. All rights reserved.
20 
 
 
22. Vos MB, Kimmons JE, Gillespie C, Welsh J, Blanck HM. Dietary fructose consumption 
among US children and adults: the Third National Health and Nutrition Examination Survey. 
Medscape J Med 2008;10:160. 
23. Burdette HL, Whitaker RC, Daniels SR. Parental report of outdoor playtime as a measure 
of physical activity in preschool-aged children. Arch Pediatr Adolesc Med 2004;158:353-357. 
24. National Center for Health Statistics. CDC Growth Charts, United States. In; 2000. 
25. Shorr I. How to weigh and measure children. In. New York: UN; 1986. 
26. Mueller WH, Martorell R. Reliability and accuracy of measurement. Champaign, IL: 
Human Kinetics Books, 1988. 
27. United States Department of Agriculture. Scientific Report of the 2015 Dietary 
Guidelines Advsory Committee. In. https://health.gov/dietaryguidelines/2015-scientific-
report/PDFs/Scientific-Report-of-the-2015-Dietary-Guidelines-Advisory-Committee.pdf; 2015. 
28. Lavine JE, Schwimmer JB, Van Natta ML, Molleston JP, Murray KF, Rosenthal P, 
Abrams SH, et al. Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver 
disease in children and adolescents: the TONIC randomized controlled trial. Jama 
2011;305:1659-1668. 
29. Hoofnagle JH, Van Natta ML, Kleiner DE, Clark JM, Kowdley KV, Loomba R, 
Neuschwander-Tetri BA, et al. Vitamin E and changes in serum alanine aminotransferase levels 
in patients with non-alcoholic steatohepatitis. Aliment Pharmacol Ther 2013;38:134-143. 
30. Mah E, Sapper TN, Chitchumroonchokchai C, Failla ML, Schill KE, Clinton SK, Bobe 
G, et al. alpha-Tocopherol bioavailability is lower in adults with metabolic syndrome regardless 
of dairy fat co-ingestion: a randomized, double-blind, crossover trial. Am J Clin Nutr 
2015;102:1070-1080. 
Page 20 of 27
Hepatology
Hepatology
This article is protected by copyright. All rights reserved.
Table 1. Parent and child characteristics according to early childhood vitamin E (alpha-tocopherol) intake. Data from 528 mother-child pairs. 
 Overall Early Childhood Vitamin E (alpha-Tocopherol) Intake Quartile 
  1 2 3 4 
N  528 132  131 133 132  
Family/Household characteristic      
Maternal age, mean ± SD, y 32.2 ± 5.3 32.1 ± 5.0 31.8 ± 5.2 32.0 ± 5.2 32.7 ± 5.9 
Education, college graduate, n,% 366 (69) 95 (72) 90 (69) 95 (71) 86 (65) 
Parity, multipara, n, % 299 (57) 73 (55) 72 (55) 76 (57) 78 (59) 
Marital status, married/cohabiting, n, % 472 (89) 121 (92) 118 (90) 117 (88) 116 (88) 
Annual household income at early childhood, n, %      
<$40,000/y 84 (16) 14(11) 19 (14) 27 (20) 24 (18) 
$40-70,000/y 106 (20) 26 (20) 28 (21) 22 (16) 30 (23) 
>$70,000/y 327 (63) 89 (69) 80 (63) 83 (63) 75 (58) 
Maternal pre-pregnancy BMI, mean ± SD, kg/m2 24.8 ± 5.2 24.4 ± 5.0 24.6 ± 4.7 25.1 ± 5.4 25.0 ± 5.5 
Paternal pre-pregnancy BMI, mean ± SD, kg/m2 26.4 ± 3.7 26.7 ± 3.8 26.6 ± 3.5 26.4 ± 3.9 25.0 ± 5.4 
Child      
Girl, n, % 254 (48) 55 (42) 61 (47) 74 (56) 64 (48) 
Age early childhood vitamin E (alpha-tocopherol) 
intake measurement, mean ± SD, mo 
38.3 ± 2.6 37.8 ± 1.8 37.9 ± 2.2 38.6±2.6 38.8±3.6 
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Age mid-childhood blood draw,  mean ± SD, mo 94.2 (8.9) 94.4 (9.1) 92.6 (7.9) 95.6 (10.0) 94.0 (8.4) 
BMI z-score, mid-childhood, mean ± SD 0.41 ± 1.0 0.24±0.8 0.51±1.0 0.54±1.0 0.37±1.1 
BMI category, mid-childhood, n, %      
<5th percentile 12 (2.3) 1 (0.8) 4 (3.1) 1 (0.8) 6 (4.5) 
5th to <85th percentile 371 (70.3) 107 (81.1) 87 (66.4) 91 (68.4) 86 (65.2) 
85th to <95th percentile 74 (14.0) 17 (12.9) 16 (12.2) 17 (12.8) 24 (18.2) 
≥95th percentile 71 (13.4) 7 (5.3) 24 (18.3) 24 (18.0) 16 (12.1) 
Race/ethnicity, n, %      
Asian 13 (2) 4 (3) 4 (3) 3 (2) 2 (2) 
Hispanic 21 (4) 6 (5) 7 (5) 5 (4) 3 (2) 
White, non-Hispanic 332 (63) 93 (70) 80 (61) 84 (63) 75 (57) 
Black, non-Hispanic 98 (19) 14 (11) 24 (18) 24 (18) 36 (27) 
Other/More than 1 race 64 (12) 15 (11) 16 (12) 17 (13) 16 (12) 
aAll estimates of vitamin E (alpha-tocopherol) intake were adjusted for total energy intake using the nutrient residual method.  
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Table 2. Energy-adjusted vitamin E (alpha-tocopherol) intake during early childhood according to mid-childhood plasma ALT levels. 
Data from 528 mother-child pairs.  
 
 
Overall  
(N=528) 
Children with normal ALT level
a
 
(N=411) 
Children with high ALT level 
(N=117) 
Early Childhood Nutrient Intake Mean ± SD or N (%) 
Total energy, mean ± SD, kcal 1871 ± 539 1885 ± 548 1822 ± 506 
Vitamin E (alpha-tocopherol)b , mean ± SD, 
mg 
3.7 ± 1.0 3.7 ± 1.0 3.6 ± 1.0 
Vitamin E (alpha-tocopherol)b, mg, n (%), 
quartiles 
   
Q1 (< 3.0) 132 (25.0) 95 (23.1) 37 (31.6) 
Q2 (3.0 to < 3.6) 131 (24.8) 100 (24.3) 31 (26.5) 
Q3 (3.6 to < 4.2) 133 (25.2) 112 (27.2) 21 (18.0) 
Q4 (≥ 4.2) 132 (25.0) 104 (25.3) 28 (23.9) 
a  Normal ALT defined as < 22.1 units per liter for females and < 25.8 units per liter for males 
b All estimates of vitamin E (alpha-tocopherol) intake were adjusted for total energy intake using the nutrient residual method.
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Table 3. Multivariable regression models for association of energy-adjusted vitamin E (alpha-tocopherol) intake during early 
childhood with elevation in ALT levels at mid-childhood.  Data from 528 children in Project Viva.  
 
 Unadjusted Covariate-
adjusted Model
a
 
Diet-adjusted 
Model
b
 
BMIz-adjusted 
Model
c
 
Diet and BMIz-
adjusted Model
d
 
 OR (95% CI) 
Early Childhood Vitamin E 
(alpha-tocopherol) Intake 
 
Low Vitamin E (alpha-tocopherol) 
Intake 
     
1st quartile 1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 
2nd-4th quartiles 
0.65 (0.41, 1.02) 0.62 (0.39, 0.99) 
0.62 (0.36, 1.08) 0.55 (0.34, 0.89) 0.56 (0.32, 0.99) 
 
Quartiles of Vitamin E  
(alpha-tocopherol) Intake 
    
 
1st quartile 1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 
2nd quartile 0.80 (0.46, 1.38) 0.80 (0.46, 1.41) 0.82 (0.45, 1.50) 0.70 (0.39, 1.24) 0.74 (0.40, 1.37) 
3rd quartile 0.48 (0.26, 0.88) 0.43 (0.23, 0.80) 0.40 (0.20, 0.80) 0.37 (0.20, 0.69) 0.35 (0.17, 0.72) 
4th quartile 0.69 (0.39, 1.22) 0.67 (0.38, 1.20) 0.66 (0.28, 1.55) 0.63 (0.35, 1.14) 0.67 (0.28, 1.58) 
Bold indicates statistically significant values where the 95% CI does not cross the null. 
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aCovariate-adjusted model: Adjusted for child sex, race/ethnicity, and age at time of mid-childhood visit 
bDiet-adjusted model: Covariate-adjusted model additionally adjusted for fruit and vegetable intake; and energy-adjusted saturated fat, 
polyunsaturated fat, fructose, vitamin D, and vitamin C at early childhood visit 
cBMIz-adjusted model: Covariate-adjusted model additionally adjusted for child BMI z-score at mid-childhood visit 
dDiet and BMIz-adjusted Model: Diet-adjusted model additionally adjusted for BMI z-score at mid-childhood visit 
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FIGURE LEGEND 
 
Figure 1. Association of energy-adjusted alpha-tocopherol intake during early childhood with elevation 
in alanine aminotransferase levels at mid-childhood adjusted for specified food groups and nutrients. 
Data from 528 children in Project Viva. 
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120x88mm (300 x 300 DPI)  
 
 
Page 27 of 27
Hepatology
Hepatology
This article is protected by copyright. All rights reserved.
